USANA Health Sciences (NYSE:USNA) Stock Price Up 3.8% – Time to Buy?

USANA Health Sciences, Inc. (NYSE:USNA)’s share price was up 3.8% during trading on Wednesday . The company traded as high as $27.17 and last traded at $27.25. Approximately 42,753 shares traded hands during trading, a decline of 60% from the average daily volume of 107,029 shares. The stock had previously closed at $26.26.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. DA Davidson reduced their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday, February 27th. Finally, StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th.

USANA Health Sciences Stock Down 1.1 %

The stock’s fifty day simple moving average is $31.15 and its 200-day simple moving average is $35.09. The company has a market capitalization of $526.37 million, a PE ratio of 9.84, a PEG ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. The business had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, CEO Jim Brown sold 5,000 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the transaction, the chief executive officer now directly owns 15,716 shares in the company, valued at approximately $463,150.52. The trade was a 24.14 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Joshua Foukas sold 5,732 shares of the firm’s stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total value of $186,519.28. The disclosure for this sale can be found here. Insiders sold a total of 15,920 shares of company stock valued at $500,285 in the last ninety days. Corporate insiders own 0.33% of the company’s stock.

Hedge Funds Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently bought and sold shares of USNA. Dimensional Fund Advisors LP grew its position in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after acquiring an additional 55,059 shares during the period. Pacer Advisors Inc. lifted its stake in shares of USANA Health Sciences by 8.8% in the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock valued at $21,247,000 after purchasing an additional 47,745 shares in the last quarter. Pzena Investment Management LLC grew its holdings in shares of USANA Health Sciences by 3.6% during the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock worth $39,015,000 after purchasing an additional 37,466 shares during the period. Jane Street Group LLC increased its position in USANA Health Sciences by 330.0% during the 4th quarter. Jane Street Group LLC now owns 39,979 shares of the company’s stock worth $1,435,000 after purchasing an additional 30,681 shares in the last quarter. Finally, Norges Bank purchased a new position in USANA Health Sciences in the fourth quarter valued at approximately $953,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.